Innovations in oncology continue to accelerate with new diagnostic platforms and targeted therapies. Dana-Farber introduced MARLIN, an AI-driven methylation-based leukemia subtype classifier, enhancing precision in acute leukemia diagnostics. Additionally, Myriad Genetics and Sophia Genetics initiated a collaboration to develop liquid biopsy companion diagnostics for cancer patients, aiming for global regulatory submissions. Meanwhile, promising antibody-based and PROTAC therapies are advancing for various cancers including cervical, ovarian, and glioblastoma, demonstrating the continual pipeline evolution in oncology.